Meeting on the risk assessment of the new psychoactive substance acryloylfentanyl
The extended Scientific Committee of the EMCDDA met on 22 February 2017 to examine the risk assessment by the EMCDDA on N-(1‑phenethylpiperidin-4-yl)-N-phenylacrylamide (acryloylfentanyl).
